Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Get ready for wider availability of the OraQuick HIV-1/2 rapid HIV test: with a June 2004 waiver issued by the Food and Drug Administration (FDA), the test now can be used by more than 180,000 sites in the United States, including outreach clinics, community-based organizations, and physicians’ offices.

Broader access now available for HIV test